Catechol-O-methyltransferase Val158Met polymorphism is associated with somatosensory amplification and nocebo responses.

A large number of unwanted adverse events and symptoms reported by patients in clinical trials are not caused by the drug provided, since most of adverse events also occur in corresponding placebo groups. These nocebo effects also play a major role in drug discontinuation in clinical practice, negat...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Laura Wendt, Antje Albring, Sven Benson, Harald Engler, Andrea Engler, Anke Hinney, Winfried Rief, Oliver Witzke, Manfred Schedlowski
Format: Artykuł
Język:English
Wydane: Public Library of Science (PLoS) 2014-01-01
Seria:PLoS ONE
Dostęp online:http://europepmc.org/articles/PMC4164653?pdf=render

Podobne zapisy